Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Younger siblings, C-reactive protein, and risk of age-related macular degeneration.

Cohn AC, Busija L, Robman LD, Dimitrov PN, Varsamidis M, Lim LL, Baird PN, Guymer RH.

Am J Epidemiol. 2013 May 1;177(9):933-43. doi: 10.1093/aje/kws332. Epub 2013 Apr 1.

PMID:
23548752
2.

C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression.

Robman L, Baird PN, Dimitrov PN, Richardson AJ, Guymer RH.

Ophthalmology. 2010 Oct;117(10):1982-8. doi: 10.1016/j.ophtha.2010.02.003. Epub 2010 Jun 3.

PMID:
20605213
3.

Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration.

Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, Sato H, Loomis S, Andreoli MT, Adams SM, Radeke MJ, Jelcick AS, Yuan Y, Tsiloulis AN, Chatzoulis DZ, Silvestri G, Kotoula MG, Tsironi EE, Hollis BW, Chen R, Haider NB, Miller JW, Farrer LA, Hageman GS, Kim IK, Schaumberg DA, DeAngelis MM.

Hum Genomics. 2011 Oct;5(6):538-68.

4.

C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.

Seddon JM, Gensler G, Rosner B.

Ophthalmology. 2010 Aug;117(8):1560-6. doi: 10.1016/j.ophtha.2009.11.020. Epub 2010 Mar 26.

5.

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.

Kim IK, Ji F, Morrison MA, Adams S, Zhang Q, Lane AM, Capone A, Dryja TP, Ott J, Miller JW, DeAngelis MM.

Mol Vis. 2008 Aug 11;14:1487-95.

6.

Identification of urinary biomarkers for age-related macular degeneration.

Guymer RH, Tao LW, Goh JK, Liew D, Ischenko O, Robman LD, Aung K, Cipriani T, Cain M, Richardson AJ, Baird PN, Langham R.

Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4639-44. doi: 10.1167/iovs.10-7120.

PMID:
21498607
7.

Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.

Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V, Silvestri G, Chakravarthy U.

PLoS Med. 2007 Dec;4(12):e355.

8.

Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration.

Vine AK, Stader J, Branham K, Musch DC, Swaroop A.

Ophthalmology. 2005 Dec;112(12):2076-80. Epub 2005 Oct 12.

PMID:
16225921
9.

Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population.

Simonelli F, Frisso G, Testa F, di Fiore R, Vitale DF, Manitto MP, Brancato R, Rinaldi E, Sacchetti L.

Br J Ophthalmol. 2006 Sep;90(9):1142-5. Epub 2006 Jun 14.

10.

Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations.

Keilhauer CN, Fritsche LG, Guthoff R, Haubitz I, Weber BH.

Eur J Med Genet. 2013 Feb;56(2):72-9. doi: 10.1016/j.ejmg.2012.10.005. Epub 2012 Oct 25.

PMID:
23103884
11.

[Age related macular degeneration and C-reactive protein].

Stefan C, Dumitrica DM, Tebeanu E, Sapundgieva A, Dragomir L, Cristea I.

Oftalmologia. 2008;52(3):73-6. Romanian.

PMID:
19149122
12.

Family history and age-related maculopathy: the Blue Mountains Eye Study.

Smith W, Mitchell P.

Aust N Z J Ophthalmol. 1998 Aug;26(3):203-6.

PMID:
9717749
13.

CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.

Seddon JM, George S, Rosner B, Klein ML.

Hum Hered. 2006;61(3):157-65. Epub 2006 Jun 30.

PMID:
16816528
14.
15.

Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration.

Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tseng SH, Tsai FJ.

Am J Ophthalmol. 2008 Jun;145(6):1045-1051. doi: 10.1016/j.ajo.2008.01.027. Epub 2008 Apr 18.

PMID:
18378209
16.

Complement factor H polymorphism in age-related macular degeneration.

Narayanan R, Butani V, Boyer DS, Atilano SR, Resende GP, Kim DS, Chakrabarti S, Kuppermann BD, Khatibi N, Chwa M, Nesburn AB, Kenney MC.

Ophthalmology. 2007 Jul;114(7):1327-31. Epub 2007 Feb 16.

PMID:
17306880
17.

Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes.

Thompson CL, Klein BE, Klein R, Xu Z, Capriotti J, Joshi T, Leontiev D, Lee KE, Elston RC, Iyengar SK.

Hum Mol Genet. 2007 Sep 1;16(17):2135-48. Epub 2007 Jun 25.

PMID:
17591627
18.

Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.

van de Ven JP, Smailhodzic D, Boon CJ, Fauser S, Groenewoud JM, Chong NV, Hoyng CB, Klevering BJ, den Hollander AI.

Mol Vis. 2012;18:2271-8. Epub 2012 Aug 18.

19.

Age-related macular degeneration is associated with increased proportion of CD56(+) T cells in peripheral blood.

Faber C, Singh A, Krüger Falk M, Juel HB, Sørensen TL, Nissen MH.

Ophthalmology. 2013 Nov;120(11):2310-6. doi: 10.1016/j.ophtha.2013.04.014. Epub 2013 Jun 6.

PMID:
23747161
20.

Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.

Buentello-Volante B, Rodriguez-Ruiz G, Miranda-Duarte A, Pompa-Mera EN, Graue-Wiechers F, Bekker-Méndez C, Ayala-Ramirez R, Quezada C, Rodríguez-Loaiza JL, Zenteno JC.

Mol Vis. 2012;18:2518-25. Epub 2012 Oct 11.

Supplemental Content

Support Center